Anti-anxiety effect of a novel 5-HT3 receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice

dc.contributor.authorMahesh, R.
dc.date.accessioned2023-11-20T09:11:32Z
dc.date.available2023-11-20T09:11:32Z
dc.date.issued2014
dc.description.abstractTo investigate the anti-anxiety activity of “6k”, a novel 5-hydroxytryptamine type 3 (5-HT3) receptor antagonist in in mice.en_US
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912791/
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13186
dc.language.isoenen_US
dc.publisherWolters Kluweren_US
dc.subjectPharmacyen_US
dc.subject5-HT3 antagonisten_US
dc.subjectAnxietyen_US
dc.subjectElevated plus maze (EPM)en_US
dc.subjectOpen field test (OFT)en_US
dc.subjectHole board test (HBT)en_US
dc.titleAnti-anxiety effect of a novel 5-HT3 receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in miceen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: